ACAD8
Basic information
Region (hg38): 11:134253548-134265855
Links
Phenotypes
GenCC
Source:
- isobutyryl-CoA dehydrogenase deficiency (Strong), mode of inheritance: AR
- isobutyryl-CoA dehydrogenase deficiency (Strong), mode of inheritance: AR
- isobutyryl-CoA dehydrogenase deficiency (Supportive), mode of inheritance: AR
- isobutyryl-CoA dehydrogenase deficiency (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Isobutyryl-CoA dehydrogenase deficiency | AR | Biochemical | Metabolic precautions may be beneficial to prevent and treat acute decompensation; Medical treatment (eg, with oral L-carnitine) has been reported as allowing growth catch-up and normalization of cardiac status | Biochemical; Cardiovascular; Hematologic; Musculoskeletal; Neurologic | 9889013; 12359132; 17304052; 16857760; 17924841; 21290185; 22241096 |
ClinVar
This is a list of variants' phenotypes submitted to
- Deficiency_of_isobutyryl-CoA_dehydrogenase (182 variants)
- not_provided (75 variants)
- Inborn_genetic_diseases (42 variants)
- not_specified (8 variants)
- ACAD8-related_disorder (8 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACAD8 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000014384.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 10 | 27 | 38 | |||
| missense | 17 | 105 | 10 | 138 | ||
| nonsense | 9 | |||||
| start loss | 4 | 4 | ||||
| frameshift | 3 | |||||
| splice donor/acceptor (+/-2bp) | 11 | |||||
| Total | 18 | 27 | 119 | 37 | 2 |
Highest pathogenic variant AF is 0.00023606591
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| ACAD8 | protein_coding | protein_coding | ENST00000281182 | 11 | 12361 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 5.64e-14 | 0.0553 | 125678 | 0 | 70 | 125748 | 0.000278 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.222 | 221 | 231 | 0.959 | 0.0000132 | 2701 |
| Missense in Polyphen | 89 | 93.727 | 0.94956 | 1080 | ||
| Synonymous | -1.95 | 115 | 91.3 | 1.26 | 0.00000562 | 823 |
| Loss of Function | 0.508 | 22 | 24.7 | 0.890 | 0.00000156 | 246 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000561 | 0.000561 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000163 | 0.000163 |
| Finnish | 0.0000924 | 0.0000924 |
| European (Non-Finnish) | 0.000350 | 0.000334 |
| Middle Eastern | 0.000163 | 0.000163 |
| South Asian | 0.000327 | 0.000327 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Has very high activity toward isobutyryl-CoA. Is an isobutyryl-CoA dehydrogenase that functions in valine catabolism. Plays a role in transcriptional coactivation within the ARC complex. {ECO:0000269|PubMed:12359132}.;
- Pathway
- Valine, leucine and isoleucine degradation - Homo sapiens (human);3-Methylglutaconic Aciduria Type I;Valine, Leucine and Isoleucine Degradation;2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency;Isovaleric Aciduria;3-Methylcrotonyl Coa Carboxylase Deficiency Type I;Propionic Acidemia;Maple Syrup Urine Disease;3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency;Isobutyryl-coa dehydrogenase deficiency;3-hydroxyisobutyric aciduria;3-hydroxyisobutyric acid dehydrogenase deficiency;Isovaleric acidemia;Methylmalonate Semialdehyde Dehydrogenase Deficiency;Methylmalonic Aciduria;3-Methylglutaconic Aciduria Type IV;3-Methylglutaconic Aciduria Type III;Beta-Ketothiolase Deficiency;Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives;Metabolism;valine degradation
(Consensus)
Recessive Scores
- pRec
- 0.250
Intolerance Scores
- loftool
- 0.287
- rvis_EVS
- -0.38
- rvis_percentile_EVS
- 27.88
Haploinsufficiency Scores
- pHI
- 0.0217
- hipred
- N
- hipred_score
- 0.289
- ghis
- 0.530
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.992
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Acad8
- Phenotype
- adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype; liver/biliary system phenotype; renal/urinary system phenotype;
Gene ontology
- Biological process
- valine catabolic process;lipid metabolic process;branched-chain amino acid catabolic process;oxidation-reduction process
- Cellular component
- mitochondrial matrix
- Molecular function
- acyl-CoA dehydrogenase activity;flavin adenine dinucleotide binding